Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression
The DOI matches its Crossref record.
Abstract
In a double-blind study lasting for 4 weeks, the authors compared the effectiveness of amoxapine, an antidepressant with potential antipsychotic properties, with a combination of amitriptyline plus perphenazine in the treatment of 38 patients who had the diagnosis of major depression with psychotic features (psychotic or delusional depression). Patients in each group showed similar improvement in depression and psychosis. There was a tendency for the patients treated with amitriptyline plus perphenazine to have higher global response rates. However, the patients given amoxapine had significantly fewer extrapyramidal side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
An open label trial of C-1073 (mifepristone) for psychotic major depression*
Belanoff, J. K., Rothschild, A. J., Cassidy, F., DeBattista, C., Baulieu, E.-E., Schold, C., & Schatzberg, A. F. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01432-4 · Cited by 320
Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.6.733 · Cited by 317
Metabolism of Tricyclic Antidepressants
Rudorfer, M. V., & Potter, W. Z. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006949816036 · Cited by 296
Rapid Reversal of Psychotic Depression Using Mifepristone
Belanoff, J. K., Flores, B. H., Kalezhan, M., Sund, B., & Schatzberg, A. F. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00009 · Cited by 282
Guaiana, G., Barbui, C., & Hotopf, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004186.pub2 · Cited by 271
Farahani, A., & Correll, C. U. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11r07324 · Cited by 131
(2003) · PubMed · Cited by 69
Ghio, L., Natta, W., Rossi, P., Peruzzo, L., Zanelli, E., Gotelli, S., & Gabrielli, F. (2011) · Case Reports in Medicine · doi:10.1155/2011/856903 · Cited by 6
“Despite the positive results obtained, the use of these molecules has been reduced due to an undesirable high rate of adverse effects [8, 9].”
Background
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1990-09-01
- Volume
- 147
- Issue
- 9
- Pages
- 1203-1208
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W89007775
- Cited by
- 99
- References
- 0
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.